Patient Access

High Costs Drive Americans to Seek IVF Treatment Abroad
Business High Costs Drive Americans to Seek IVF Treatment Abroad

Faisal Zain stands at the forefront of the medical technology sector, bringing years of expertise in the manufacturing of diagnostic and treatment devices that have reshaped patient care. His deep understanding of medical economics allows him to dissect the complex financial structures that define

Rising Costs and Policy Shifts Strain U.S. Public Health
Business Rising Costs and Policy Shifts Strain U.S. Public Health

Faisal Zain is a distinguished figure in the medical technology sector, bringing years of expertise in the manufacturing and deployment of critical diagnostic tools. As a leader who has navigated the complexities of healthcare infrastructure, Zain offers a unique perspective on how policy changes

Can Healthcare Reform Decide California’s 22nd District?
Care Can Healthcare Reform Decide California’s 22nd District?

In the dust-caked expanses of the southern San Joaquin Valley, a hard-earned dollar can occasionally feel like a heavy liability for families balancing on the edge of the federal poverty line. While political pundits in coastal cities might obsess over global trade or identity politics, residents

Can New Tools Help Pennsylvania Stop the Measles Outbreak?
Care Can New Tools Help Pennsylvania Stop the Measles Outbreak?

The resurgence of measles in Pennsylvania has transformed from a localized concern into a significant test of the state’s modern public health infrastructure and its ability to safeguard the youngest citizens. As school systems prepare for the current academic cycle, the persistence of nearly 300 c

Patient Financing Integrates Into the Digital Front Door
Care Patient Financing Integrates Into the Digital Front Door

Faisal Zain is a cornerstone of the healthcare technology landscape, bringing decades of specialized expertise in medical diagnostics and the manufacturing of treatment devices. Throughout his career, he has observed a frustrating paradox: while we have mastered the art of high-tech clinical

Is Medicare’s GLP-1 Bridge Program Helping or Hurting?
Care Is Medicare’s GLP-1 Bridge Program Helping or Hurting?

The exclusion of patients whose conditions are already FDA-approved for GLP-1 treatment highlights a significant friction point in federal healthcare policy. For decades, the federal government maintained a rigid statutory wall that prevented Medicare from covering medications prescribed solely for

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later